Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-26

FDA Approved: LEVETIRACETAM — Supplemental Application (Civica, Inc.)

View source ↗

Summary

The FDA approved Civica, Inc.'s supplemental application for levetiracetam (generic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)